StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Wolfe Research Reiterates Outperform Rating on AnaptysBio (ANAB)
August 31, 2026 5:37 AM
Wolfe Research analyst Andy Chen reiterated an Outperform rating and $78.00 price target on AnaptysBio (NASDAQ: ANAB).The analyst comments "The ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
